GSK (LON:GSK) Stock Price Passes Above 200-Day Moving Average – What’s Next?

GSK plc (LON:GSK) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,448.19 ($18.21) and traded as high as GBX 1,478.50 ($18.60). GSK shares last traded at GBX 1,467.50 ($18.46), with a volume of 16,677,213 shares traded.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research report on Tuesday, January 7th. Berenberg Bank reduced their price target on shares of GSK from GBX 1,820 ($22.89) to GBX 1,600 ($20.12) and set a “buy” rating on the stock in a research report on Friday, November 29th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,805.83 ($22.71).

GSK Stock Up 0.4 %

The business has a 50-day moving average of GBX 1,391.65 and a 200-day moving average of GBX 1,447.40. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. The stock has a market capitalization of £59.55 billion, a price-to-earnings ratio of 23.71, a P/E/G ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK) last issued its quarterly earnings data on Wednesday, February 5th. The company reported GBX 23.20 ($0.29) earnings per share (EPS) for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. On average, sell-side analysts expect that GSK plc will post 175.980975 EPS for the current year.

Insider Transactions at GSK

In related news, insider Jonathan Symonds bought 1,500 shares of the company’s stock in a transaction dated Friday, December 20th. The shares were acquired at an average price of GBX 1,315 ($16.54) per share, with a total value of £19,725 ($24,808.20). Also, insider Emma Walmsley sold 120,653 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of GBX 1,453 ($18.27), for a total value of £1,753,088.09 ($2,204,864.91). Corporate insiders own 1.61% of the company’s stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.